Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Supporters often emphasize the opportunity for substantial therapeutic outcomes, especially in ailments where conventional treatments have proven inadequate. However, it's to assess the considerable financial burden associated with CPI stem cell t